Topic

PNB Vesper Life Sciences

1 article

PNB Vesper completes Phase 2 clinical trials of GPP-Baladol on COVID-19 patients
COVID-19 13 Feb 2021

PNB Vesper completes Phase 2 clinical trials of GPP-Baladol on COVID-19 patients

The clinical trial report will be submitted to Drug Controller General of India on February 22, 2021 Kerala-based PNB Vesper…